Gregory Downey - May 7, 2021 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Chief Financial Officer
Signature
/Gregory Downey/
Stock symbol
LEXX
Transactions as of
May 7, 2021
Transactions value $
$0
Form type
4
Date filed
6/9/2021, 12:32 PM
Next filing
Jun 9, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LEXX common shares 1.83K May 7, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LEXX Stock Options Other $0 -8K -32% $0.00 17K May 7, 2021 Common Shares 8K $9.60 Direct F1
holding LEXX Stock Options 8K May 7, 2021 Common Shares 8K $9.60 Direct
holding LEXX Stock Options 12K May 7, 2021 Common Shares 4K $5.04 Direct
holding LEXX Stock Options 16K May 7, 2021 Common Shares 4K $5.04 Direct
holding LEXX Stock Options 20K May 7, 2021 Common Shares 4K $5.04 Direct
holding LEXX Stock Options 25K May 7, 2021 Common Shares 5K $5.31 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Cancelled Options